SCHEMBL9929935

SCHEMBL9929935

CO[PH](=O)OS(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.43
ALDH1A1 P00352 9/20 0.41
HSD17B10 Q99714 1/20 0.41
HTR6 P50406 2/20 0.39
PARL Q9H300 1/20 0.39
PSIP1 O75475 1/20 0.39
MAPT P10636 6/20 0.38
LMNA P02545 4/20 0.38
XBP1 P17861 4/20 0.38
MPI P34949 4/20 0.38
NPSR1 Q6W5P4 4/20 0.38
S1PR2 O95136 3/20 0.38
PKM P14618 2/20 0.38
HTT P42858 2/20 0.38
RAB9A P51151 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPK1 P28482 2/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727540 0.87 TDP1 (0.48) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL28987611 0.82 GAA (0.45) TDP1ALDH1A1MAPTLMNAXBP1
SCHEMBL28088043 0.81 TDP1 (0.37) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL29269086 0.80 TDP1 (0.43) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL8854485 0.76 HSD11B1 (0.40) ALDH1A1HSD17B10HTR6MAPTLMNA
SCHEMBL27543292 0.75 TSHR (0.44) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL1594136 0.73 TSHR (0.43) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL94530 0.73 HTR6 (0.50) TDP1ALDH1A1HSD17B10HTR6PARL
SCHEMBL8854426 0.73 ATM (0.34) TDP1ALDH1A1KMT2A
SCHEMBL1593307 0.73 TDP1 (0.38) TDP1ALDH1A1HSD17B10HTR6PARL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114409706-B Preparation method of phenyl hydrogen phosphonate and intermediate thereof 上海医药工业研究院 2023-11-28 CN claimed
CN-114409706-B Preparation method of phenyl hydrogen phosphonate and intermediate thereof 上海医药工业研究院 2023-11-28 CN disclosed
CN-105998039-A Phosphonate ester derivatives and methods of synthesis thereof 奇默里克斯公司 2016-10-12 CN disclosed
CN-102939291-B Phosphonate ester for the toxicity with reduction for the treatment of of viral infections 加利福尼亚大学董事会 2016-09-07 CN disclosed
CN-103209985-B Phosphonate derivatives and methods of synthesis thereof 奇默里克斯公司 2016-08-24 CN disclosed
US-9045524-B2 Selective caspase inhibitors and uses thereof NOVAGENESIS FOUNDATION (CH) 2015-06-02 US disclosed
US-20120157394-A1 SELECTIVE CASPASE INHIBITORS AND USES THEREOF NEW WORLD LABORATORIES, INC. (CA) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157394-A1 SELECTIVE CASPASE INHIBITORS AND USES THEREOF CASP1, VIP, CASP5 TDP1 629/4885ALDH1A1 4093/4885HSD17B10 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.